Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
about
Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesProspects of immune checkpoint modulators in the treatment of glioblastomaClinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?Targeting the transforming growth factor-beta signaling pathway in human cancer.The roles of TGFβ in the tumour microenvironment.Targeting protein kinases in central nervous system disordersStable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cellsChemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.Current trends in targeted therapies for glioblastoma multiformeRecent developments on immunotherapy for brain cancer.Study on the therapeutic effect of neural progenitor cells in mice of a glioma murine modelMoxifloxacin modifies corneal fibroblast-to-myofibroblast differentiationNaringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes.The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer MetastasisPrioritization schema for immunotherapy clinical trials in glioblastoma.Combating immunosuppression in gliomaPPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion.Advances in Immunotherapy for Glioblastoma Multiforme.Cytokine networks in glioma.TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases.Microenvironmental clues for glioma immunotherapy.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.The Dynamics of Interactions Among Immune and Glioblastoma Cells.PPAR-gamma Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors.TGF-β-induced hCG-β regulates redox homeostasis in glioma cells.Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastomaRosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors.Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142).Role of Macrophages in Brain Tumor Growth and Progression.Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.
P2860
Q26798402-32005B2E-1303-46EB-B259-663E2343DCE2Q28081371-F5354D0F-4F0F-4925-A081-DE9873C37250Q28084351-B906C4DA-A91F-4BB1-8DAB-665ECE8346E1Q33517772-94621766-686D-48E9-B959-260B5CDD766CQ33630845-3A8133B3-2463-47BF-8750-109BEBAA6FCEQ33671660-3FF123DB-755F-4AE2-9AB7-2FAE942DF82DQ34645287-33B3DF75-3991-4F84-8217-D8A10926CCDAQ35490960-99549C45-832E-4F96-B924-1A82DB81A0DEQ35815273-63B0B95A-9BFA-4D9F-A6E5-62E8C75986D3Q35864226-65F73769-2FA0-4F29-B31F-6D1DB70A90BBQ35992355-71871D4D-97DD-4318-9236-AC7C2A236835Q36650448-DC83D11D-44B1-4DC1-A5A3-6029A21B0E30Q36681754-681C0CFE-6EC2-4B4C-A589-0574C768E501Q36758301-D4E1B14F-A95D-4D11-A4E9-8D4231327C4DQ36922514-75F1C57F-C62F-4D77-B67C-D3F78715B57CQ36985643-8DFBF790-ADB4-49D2-B6A3-6DD002196E00Q37078999-75DD272C-D9CC-46BB-A32E-916E14CF0FDBQ37179415-67CB8C1E-7116-483C-A533-289AC0DAA94CQ37278858-0FD62159-3E67-4C8F-BE43-555CF76CEED8Q37680966-98D2C724-80C8-4B09-AE98-9025BA51C5B4Q37886819-6BE06316-4D07-47D1-9867-103FACFFCB48Q37900199-BF842968-46E1-4BC0-9EC8-1EC000224878Q38194054-F49A8C32-4C3F-40EF-883C-38CA1C1DD2B0Q38227889-B74AC97D-392F-4071-A920-8213E1DA99BAQ38557236-504EF21A-6779-49A9-BA7B-9AE66DF03CE7Q38620031-B94676D2-B24F-4663-A042-8F1AEA5F6969Q38949348-EACC58BD-796F-4856-BD76-1E97EFB1F700Q38962204-0956EA8A-568E-4A4E-BDB5-4D94413EBB5FQ39329694-B84B4108-18B8-4385-ADE9-47B1B3B72C4AQ42113451-19C040CA-70D5-47A1-84CB-4B79AB0F5C52Q42380337-1C55E742-D389-42CE-9A0C-AFF38189A9E9Q42732702-AC0B8BFA-0631-4E71-A4CC-1DCA47C31853Q52628012-FA5837C2-F1C0-4D1B-AAB6-9272714BB56AQ55459483-B1633934-2CCF-41FA-8636-E82F8BA840E5
P2860
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
@en
type
label
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
@en
prefLabel
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
@en
P2093
P2860
P1433
P1476
Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
@en
P2093
Alison Murphy
Andrew A Protter
Andrew Lam
Ann M Kapoun
Barry Hart
Darin E Kizer
Darren H Wong
Glenn McEnroe
Heather K Webb
Irene Kerr
P2860
P304
P356
10.1215/15228517-2007-010
P577
2007-05-23T00:00:00Z